On 3 December in Brussels, we brought together 16 ACN’s partners associations from 12 countries to examine vaccines from a crucial angle: research. From the development pathway to what’s next.
The debate focused on new platforms and delivery methods, as well as the idea of “future vaccines”.
We also explored how giving clinical trial participants access to their own data can build trust and understanding. To know more, click here for all the materials presented, here, and here to see some pictures from the day.